New Procedure Can Replace Coumadin in Some Customers with Atrial Fibrillation

North Memorial Better Health Blog Author Logo
March 28, 2017

North Memorial Health cardiologists will soon offer an innovative one-time procedure that reduces the risk of stroke in non-valvular atrial fibrillation (NVAF) customers who are unable to tolerate long-term warfarin use.

The WATCHMAN™ Implant closes off the left atrial appendage (LAA), preventing blood clots from migrating out of it. The LAA is where over 90 percent of stroke-causing clots originate in customers with atrial fibrillation.

Candidates for the WATCHMAN™ Implant:

  • Have non-valvular atrial fibrillation
  • Have increased risk for stroke (CHADS > 2 or CHDS2Vasc > 3)
  • Are suitable for short-term warfarin use (about 45 days post-procedure)
  • Have an appropriate reason to seek a non-pharmacologic alternative to warfarin (high fall risk, recurrent bleeds, etc.).

The hour-long procedure will be performed under general anesthesia in the North Memorial Catheterization Lab. Customers typically stay in the hospital overnight.  For information on referring customers for the procedure at North Memorial, contact the North Memorial Heart & Vascular program at (763) 581-5403.